Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms by Histologic Type × CP protocol × 90 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 3 Non Small Cell Lung Carcinoma NSCLC 2 Uterine Cervical Neoplasms 1 Ovarian Neoplasms 1 Non-Small Cell Lung Cancer With HER2- Mutations 1 Neoplasms 1 Lung Neoplasms 1 Breast Neoplasms 1

Interventions

fludarabine 3 fludarabine phosphate 2 Whole-Body Irradiation 2 Tacrolimus 2 Peripheral Blood Stem Cell Transplantation 2 Patient Reported Outcome Measures 2 Mycophenolic Acid 2 Mesna 2 Melphalan 2 Cyclophosphamide 2 Busulfan 2 trametinib 1 repotrectinib 1 pralsetinib 1 ponatinib 1 pembrolizumab 1 gilteritinib 1 durvalumab 1 dabrafenib 1 Pemetrexed 1 Paclitaxel 1 Immunotherapy 1 Idarubicin 1 Granulocyte Colony-Stimulating Factor 1 Gemcitabine 1 Cytarabine 1 Cisplatin 1 Carboplatin 1 Bone Marrow Transplantation 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡